|
|
|
| Webinar: Step Inside IQVIA One Home for Sites™ | Clinical research sites have been asking for single sign-on (SSO) for a decade. In this webinar, you’ll learn why 2025 will be the year when sites will finally begin to feel relief from technology overload. Discover why whether you’re with a sponsor, site, and technology vendor, it's time for you to move into One Home and join this industry collaboration. Click here to learn more. |
|
|
|
| Were There Any Surprises In Clinical Trials In 2024? | From The Editor | By Dan Schell, chief editor, Clinical Leader | Is it any surprise that when I asked a group of clinical trial industry experts to summarize some of the things that stood out to them in 2024, that AI would be mentioned more than once? Probably not. Resistance to DCTs, increasing regulatory scrutiny, and a slowdown in CRO M&As also made their lists — but I’m guessing none of that surprises you, either. |
|
|
|
| The Final DCT Guidance: I'm Not Mad At It | Article | By Catherine Gregor, Florence Healthcare | Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors. |
|
|
| Mobile Research Units Enable Large Volume Screenings | Case Study | PCM Trials | Learn how recruitment and screening of potential patients was made possible for a Phase 3, adult patients, clinical trial by utilizing MRUs to screen large volumes of patients at community events. |
|
|
|
| We Are All Project Managers, But We Need Help | From The Editor | By Dan Schell, chief editor, Clinical Leader | Jess Thompson is a champion of project managers. Not only is she working to validate their role in the clinical trial ecosystem, she wants to spread the word that we all perform PM-types of duties. Also, if the industry can improve its incorporation of those basic tenets of project management, perhaps we could see more drugs succeed — and quicker. |
|
|
|
| 'Diabesitology': Novel Trial Designs In The GLP-1 Axis Medications Era | Article | By Jamie P. Dwyer, MD, Utah DCC, PI of the Collaborative Study Group, Co-Founder of Corventum, Biorasi Scientific Advisory Board Member | Find out how today’s FDA-approved obesity medications are primed to become tomorrow’s novel treatments across multidimensional states of disease — from diabetes to heart failure. |
|
|
| Adapting Clinical Strategies For Rapid Response | Webinar | Novotech | This presentation aims to equip sponsors, researchers, and stakeholders with the tools to enhance trial resilience and ensure continuity in today’s unpredictable global landscape. |
|
|
| Select The Right BOIN Design For Your Oncology Study | Infographic | Worldwide Clinical Trials | Produce effective, reliable results in Phase 1 oncology trials with Bayesian Optimized Interval (BOIN) designs. These designs enable you to determine the MTD or the OBD with ease. |
|
|
|
| Launch Strategy & Planning | Brochure | IQVIA Biotech | Read how IQVIA Biotech can help you integrate recent market dynamics and longer-term trends into your launch strategy for a precise understanding of launch risks and expectations. |
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
